Chase Pharmaceuticals focuses on the development of medications for the treatment of neurodegenerative disorders.
Business Model:
Revenue: $1M
Employees: 51-200
Chase Pharmaceuticals was acquired by
Allergan.
The acquisition happend on 2016-11-22.
Details of the transaction were not public
Address: 1825 K St NW
City: Washington
State: district of columbia
Zip: 20006
Country: US
Chase Pharmaceuticals focuses on the development of medications for the treatment of neurodegenerative disorders.
Contact Phone:
+12027924621
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2016 | Series B | $3.5M | 5/2014 | Series B | $6.1M |
Edmond de Rothschild Investment Partners Brain Trust Accelerator Fund New Rhein Healthcare Investors, LLC Cipla |
3/2016 | Equity | $12M |
Cipla Ltd Edmond de Rothschild Investment Partners New Rhein Healthcare LLC |
8/2015 | Equity | $3.5M | 11/2010 | Equity | $1.2M | 8/2015 | Venture Round | $3M | 5/2014 | Series B | 3 | $21M |
Cipla New Rhein Andera Partners New Rhein Cipla New Rhein Andera Partners New Rhein |
12/2010 | Series A | $1.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|